Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
Digital Partner Content Axtria and Kedaara Capital Announce Strategic $240 Million I... The transaction delivers total liquidity of $240 million, making it one of the largest employee-centric liquidity events in the industry.
Digital Axtria Ignite 2025: Ritesh Mehra talks AI, culture, and comm... At Axtria Ignite 2025, web editor Nicole Raleigh spoke with Ritesh Mehra, CFO, US, at Ferring Pharmaceuticals.
Digital Sponsored Axtria Ignite 2025: Building on GenAI’s foundation with agen... Hundreds of senior executives representing major pharma companies met last month at Axtria Ignite 2025 to discuss the future of agentic AI in the industry.
Digital Sponsored Axtria Ignite 2025: Jaswinder Chadha on driving life science... At Axtria Ignite 2025, web editor Nicole Raleigh spoke with the company’s co-founder, president, and CEO Jaswinder Chadha.
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.